MedTrace Logo

Pericapsular Nerve Group Block for Hip Fractures

NCT04882384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-21

No results posted yet for this study

Summary

This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.

Conditions

  • Hip Fractures
  • Pain, Acute

Interventions

PROCEDURE

Pericapsular Nerve Group Block

This will be a peripheral nerve block.

Sponsors & Collaborators

  • Jacobi Medical Center

    lead OTHER

Principal Investigators

  • Michael Halperin · Jacobi Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-03-15
Completion
2022-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04882384 on ClinicalTrials.gov